Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development; Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways; and Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33. Zura Bio Limited was founded in 2021 and is based in Henderson, Nevada.

Zura Bio Limited

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zura Bio (ZURA), Insmed (INSM) and Harmony Bioscie...

Analysts Conflicted on These Healthcare Names: Zura Bio (ZURA), Insmed (INSM) and Harmony Biosciences Holdings (HRMY)

With markets very volatile, some investors might be hunting for stocks in the under‑$10 range but with solid growth potential. These low‑priced nam...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ZURA	$5.52	+5.14%	340.02K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ZURA	$5.52	+5.1%	340.02K
3
4
5
6

ZURA

ZURA

Get Zura Bio Limited Data in Excel

Get Zura Bio Limited Data in Excel